Skip to content

Public FDA record

Z-1271-2014: MEVION S250, System, Radiation Therapy, Charged-Particle, Medical used for Proton Radiation Therapy Prod

Recall record Z-1271-2014 for Mevion Medical Systems, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1271-2014
Company in FDA record
Mevion Medical Systems, Inc.
FDA classification date
Mar 22, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Geometric positioning error can occur after a rotational correction has been applied to one or more treatment fields

Source facts

Action
Mervion issued an Important Safety Notice letter on March 5, 2014 by visit to sites to the single customer using the product to prevent the use of multiple isocenters treatment modalities. The letter identified the affected product, problem and actions to be taken. For questions call 978-540-1555.
Initiated
2014-03-05
Root cause
Software design
Terminated
2014-04-03
Distribution
USA Nationwide Distribution in the state of MO
Recall number
Z-1271-2014
Recall status
Terminated
CDRH record ID
125920
FDA classified
2014-03-22
Recall event number
67657

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗